Pediatric Exclusivity Sales Triggers May Be Proposed In Senate Mark-Up
Executive Summary
Proposals to tie the length of pediatric exclusivity to product sales raise questions about FDA's ability to track commercial performance, Sen. Dodd (D-Conn.) said during a May 8 hearing of the Senate Health Committee.